Application of Tetracycline Regulatable Systems for Gene Therapy
Many diseases candidates for gene therapy require that the therapeutic gene expression level is controlled in order to ensure biological efficacy and to prevent toxic effects. Various systems have been described which allow transcriptional regulation by artificial chimeric transactivators in mammalian cells. This paper describes the tetracycline regulatable systems and discuss their potential application for gene therapy.
KeywordsZinc Toxicity Estrogen Leukemia Cadmium
Unable to display preview. Download preview PDF.
- Cayrot, C., and Flemington, E. K. (1995). Identification of cellular target genes of the Epstein-Barr virus transactivator Zta activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-betal. J. Virol. 69, 206–212.Google Scholar
- Davis, J. L., Gross, P. R., and Danos, O. (1997). Development and characterization of a translationally regulated retroviral vector. Abstract, Keystone Meeting, April 13–19, 21.Google Scholar
- Goossen, B., Wright Caughman, S., Harford, J. B., Klausner, R. D., and Hentze, M. W. (1990). Translational repression by a complex between the iron-responsive element of ferritin mRNA and its specific cytoplasmic binding protein is position dependent in vivo. EMBO J. 9, 4127–4133.PubMedGoogle Scholar
- Hu, M. C. T., and Davidson, N. (1990). A combination of derepression of the lac operator-repressor system with positive induction by glucocorticoid and metal ions provides a high-level-inducible gene expression system based on the human metallothionein-IIA promoter. Mol. Cell. Biol. 10, 6141–6451.PubMedGoogle Scholar
- Searl, P. F., Stuart, G. W., and Palmiter, R. D. (1985). Building a Metal-Responsive Promoter With Synthetic Regulatory Elements. Mol. Cell. Biol. 5, 1480–1489.Google Scholar
- Staeheli, P., Danielson, P., Haller, O., and Sutcliffe, J. G. (1986). Transcriptional activation of the mouse Mx gene by type 1 interferon. Mol. Cel. Biol. 6, 4770–4774.Google Scholar